Genotype Distribution and Characteristics of Chronic Hepatitis C Infection in Estonia, Latvia, Lithuania, and Ukraine: The RESPOND-C Study

Background and objectives: Since 2013, highly effective direct-acting antiviral (DAA) treatment for chronic hepatitis C (CHC) has become available, with cure rates exceeding 95%. For the choice of optimal CHC treatment, an assessment of the hepatitis C virus (HCV) genotype (GT) and liver fibrosis st...

Descripción completa

Detalles Bibliográficos
Autores principales: Jančorienė, Ligita, Rozentāle, Baiba, Tolmane, Ieva, Jēruma, Agita, Salupere, Riina, Buivydienė, Arida, Valantinas, Jonas, Kupčinskas, Limas, Šumskienė, Jolanta, Čiupkevičienė, Eglė, Ambrozaitis, Arvydas, Golubovska, Olga, Moroz, Larysa, Flisiak, Robert, Bondar, Borys
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534763/
https://www.ncbi.nlm.nih.gov/pubmed/37763696
http://dx.doi.org/10.3390/medicina59091577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534763/
https://www.ncbi.nlm.nih.gov/pubmed/37763696
http://dx.doi.org/10.3390/medicina59091577

Ejemplares similares